Product Offerings
Products:
Product Gallery:

Microcápsulas
Microcápsulas
Weecaps is an emerging Brazilian food tech startup focused on the microencapsulation of bioactive compounds for applications in the food, nutraceutical, and pharmaceutical industries. With innovation at its core, Weecaps leverages advanced encapsulation technologies to enhance the stability, bioavailability, and targeted delivery of functional ingredients. Operating within Brazil's dynamic health and wellness sector, Weecaps is positioned as a key enabler for brands looking to integrate next-generation functional ingredients into their products.
Weecaps specializes in the development and commercialization of microencapsulated ingredients—a technique that involves coating active substances (such as probiotics, vitamins, and minerals) in protective matrices to improve their performance in various product formats. The startup supports food and supplement manufacturers by providing encapsulated solutions that offer increased shelf life, controlled release, and masking of undesirable flavors or odors.
Weecaps operates under a B2B model, supplying ingredients for formulation in functional beverages, dietary supplements, dairy products, bakery items, and pharmaceutical capsules.
Weecaps offers a growing portfolio of microencapsulated actives, including:
Probiotics (microencapsulated)
Vitamins and Minerals
Bioactive Compounds
Customized Microencapsulation Services
These solutions help formulators overcome challenges related to taste, solubility, and ingredient interaction—especially important in high-performance functional food and supplement formulations.
Weecaps’ core value proposition lies in its scientific innovation, ingredient customization, and industrial scalability. Key differentiators include:
Weecaps combines material science with nutritional biochemistry to meet industry-specific performance demands.
As a startup, Weecaps does not publish public financial records. However:
These data points indicate strong early-stage growth and investor confidence in the company's technological edge.
Weecaps operates primarily within Brazil and is currently scaling towards international certification and export readiness. There is no record of international shipments in databases like ImportYeti or Trademo as of 2024, suggesting the company is in pre-export commercialization stages.
Pilot and commercial shipments are being managed through domestic distribution channels and formulation clients in the Brazilian health products sector.
Weecaps serves a B2B client base across several segments:
The company addresses a growing demand for stable, high-efficacy, and consumer-friendly functional ingredients.
Weecaps’ capabilities span:
These capabilities enable Weecaps to deliver fully developed, application-ready encapsulated ingredients to industrial partners.
Weecaps adheres to Brazilian food and health regulations and is preparing for expanded compliance under global standards. Current and developing certifications include:
These credentials support Weecaps' ambitions to expand its reach into regulated international markets.
As an early-stage B2B company, direct testimonials are limited. However, clients and collaborators from Brazil’s innovation ecosystem have publicly praised Weecaps for:
Mentions of successful pilot collaborations were presented during FiSA 2023 and in Embrapa innovation reports.
Weecaps is quickly establishing itself as a pioneering force in ingredient microencapsulation in Latin America, combining science, functionality, and clean-label compliance to meet the evolving needs of the global food and supplement industries.